Benefits of Therapeutic Drug Monitoring of First Line Antituberculosis Drugs
By: K Prso, N Zidekova, M Dohal, I Porvaznik, M Prso, M Kertys and J Mokry
Language: English
Page range: 45 - 55
Submitted on: Apr 29, 2020
|Accepted on: May 28, 2020
|Published on: Aug 20, 2020
Published by: Sciendo
In partnership with: Paradigm Publishing Services
Publication frequency: 3 issues per year
Keywords:
Related subjects:
© 2020 K Prso, N Zidekova, M Dohal, I Porvaznik, M Prso, M Kertys, J Mokry, published by Sciendo
This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 License.